期刊
JOURNAL OF NEUROSURGERY
卷 104, 期 3, 页码 360-368出版社
AMER ASSOC NEUROLOGICAL SURGEONS
DOI: 10.3171/jns.2006.104.3.360
关键词
frameless stereotaxy; image-guided neurosurgery; glioblastoma multiforme; cytoreduction; gross-total removal; prognosis
Object. The goal of this Study was to assess the impact of neuronavigation oil the cytoreductive treatment of solitary contrast-enhancing intracerebral tumors and Outcomes of this treatment in cases in which neuronavigation was preoperatively judged to be redundant. Methods. The authors conducted a prospective randomized study in which 45 patients, each harboring a solitary contrast-enhancing intracerebral tumor, were randomized for surgery with or without neuronavigation. Peri- and post-operative parameters under investigation included the following: duration of the procedure; surgeon's estimate of the usefulness of neuronavigation; quantification of the extent of resection, determined using magnetic resonance imaging; and the postoperative course, as evaluated by neurological examinations, the patient's quality-of-life self-assessment, application of the Barthel index and the Karnofsky Performance Scale score, and the patient's time of death. The mean amount of residual tumor tissue was 28.9% for standard Surgery (SS) and 13.8% for surgery involving neuronavigation (SN). The corresponding mean amounts of residual contrast-enhancing tumor tissue were 29.2 and 24.4%, respectively. These differences were not significant. Gross-total removal (GTR) was achieved in five patients who underwent SS and in three who underwent SN. Median survival was significantly shorter in the SN group (5.6 months compared with 9 months, unadjusted hazard ratio = 1.6): however, this difference may be attributable to the coincidental early death of three patients in the SN group. No discernible important effect oil the patients' 3-month postoperative course was identified. Conclusions. There is no rationale for the routine use of neuronavigation to improve the extent of tumor resection and prognosis in patients harboring a solitary enhancing intracerebral lesion when neuronavigation is not already deemed advantageous because of the size or location of the lesion.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据